Familial Mediterranean fever in the colchicine era: The fate of one family
β Scribed by Zemer, Deborah ;Livneh, Avi ;Pras, Mordechai ;Sohar, Ezra
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 497 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
β¦ Synopsis
In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF. Each patient represents a different stage of the amyloidotic kidney disease of FMF a n d the effect of continuous colchicine treatment on its course. Considered together, the members of this family present an almost complete clinical, genetic, and behavioral picture of the disease.
π SIMILAR VOLUMES
BEFORE 2 4 6-12 months Figure 3. Level of C4 in SLE patients before and during levamisole treatment. observations correspond to several studies previously reported, which also contradict the findings to Hadidi et al.
Recurrent polyserositis (RP) is manifested by short, self-limited attacks of fever, peritonitis, pleurisy, and arthritis. Because this disease affects mainly Jews, Armenians, Arabs, and Turks, it has also been called familial Mediterranean fever. The first symptoms occur before the age of 20 years i